CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Open-market buy Director bought 90,910 shares at $0.33 ($30,000)
- 4 Open-market buy COO, Secretary, Gen. Counsel bought 37,879 shares at $0.33 ($12,500)
- 4 Open-market buy CEO & President bought 75,758 shares at $0.33 ($25,000)
- D/A Other Amended Notice of Exempt Offering of Securities
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 4 Open-market buy CEO & President bought 33,861 shares at $0.44 ($15,000)
- DEFA14A Proxy Proxy Materials
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- DFAN14A Other Proxy Soliciting Materials
- 8-K Event Regulation FD disclosure
Page 14 of 82 · 1,637 filings